<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33006054</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>14</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1590-3478</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>12</Issue><PubDate><Year>2020</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</Title><ISOAbbreviation>Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>MicroRNAs in amyotrophic lateral sclerosis: from pathogenetic involvement to diagnostic biomarker and therapeutic agent development.</ArticleTitle><Pagination><StartPage>3569</StartPage><EndPage>3577</EndPage><MedlinePgn>3569-3577</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10072-020-04773-z</ELocationID><Abstract><AbstractText>MicroRNAs (miRNAs) are a class of endogenous non-coding small single-stranded RNAs that are 21-25 nucleotides (NTs) in length and participate in post-transcriptional gene regulation. Studies have shown that miRNA dysfunction plays a critical role in the occurrence and development of a variety of nervous system diseases, including neurodegenerative diseases. Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with an unclear etiology and is characterized by the selective invasion of motor neurons in the brain and spinal cord. Symptoms can range from mild spasms in the limbs or medulla oblongata muscles to paralysis in almost all skeletal muscles. The role of miRNAs in the pathogenesis, diagnosis, and treatment of ALS has become of greater importance to those studying ALS. In this review, we reviewed experimentally confirmed miRNAs shown to be involved in the pathogenesis of ALS and that are used as diagnostic biomarkers or therapeutic ALS agents. At present, there are at least 20-30 genes clearly related to the pathogenesis of ALS. Multiple miRNAs have been reported in different pathogenic gene models. MiRNAs could be used as biomarkers for the diagnosis of ALS; the differential expression of some miRNAs could be related to ALS prognosis. As therapeutic agents, miRNAs are still in the exploratory stage. Although encouraging results have been achieved using animal models, much research is still needed before clinical trials can ensue. However, with additional miRNA studies in ALS patients and animal models, the pathogenesis, early diagnosis, and therapy of ALS should be elucidated.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Shengjing Hospital of China Medical University, Liaoning, Shenyang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lijuan</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-1258-7614</Identifier><AffiliationInfo><Affiliation>Departments of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, 36 Sanhao Street, Heping District, Shenyang, Liaoning, 110004, People's Republic of China. cmu_lijuanzhang@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Neurol Sci</MedlineTA><NlmUniqueID>100959175</NlmUniqueID><ISSNLinking>1590-1874</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Biomarker</Keyword><Keyword MajorTopicYN="N">Diagnosis</Keyword><Keyword MajorTopicYN="N">Therapy</Keyword><Keyword MajorTopicYN="N">microRNAs</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>2</Day><Hour>5</Hour><Minute>48</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33006054</ArticleId><ArticleId IdType="doi">10.1007/s10072-020-04773-z</ArticleId><ArticleId IdType="pii">10.1007/s10072-020-04773-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Santa-Maria I, Alaniz ME, Renwick N, Cela C, Fulga TA, Van Vactor D, Tuschl T, Clark LN, Shelanski ML, McCabe BD, Crary JF (2015) Dysregulation of microRNA-219 promotes neurodegeneration through post-transcriptional regulation of tau. J Clin Invest 125(2):681&#x2013;686. https://doi.org/10.1172/jci78421</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci78421</ArticleId><ArticleId IdType="pubmed">25574843</ArticleId><ArticleId IdType="pmc">4319412</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Deng MF, Xiong W, Xie AJ, Guo J, Liang ZH, Hu B, Chen JG, Zhu X, Man HY, Lu Y, Liu D, Tang B, Zhu LQ (2019) MicroRNA-26a/death-associated protein kinase 1 signaling induces synucleinopathy and dopaminergic neuron degeneration in Parkinson&#x2019;s disease. Biol Psychiatry 85(9):769&#x2013;781. https://doi.org/10.1016/j.biopsych.2018.12.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2018.12.008</ArticleId><ArticleId IdType="pubmed">30718039</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng L, Doecke JD, Sharples RA, Villemagne VL, Fowler CJ, Rembach A, Martins RN, Rowe CC, Macaulay SL, Masters CL, Hill AF (2015) Prognostic serum miRNA biomarkers associated with Alzheimer's disease shows concordance with neuropsychological and neuroimaging assessment. Mol Psychiatry 20(10):1188&#x2013;1196. https://doi.org/10.1038/mp.2014.127</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2014.127</ArticleId><ArticleId IdType="pubmed">25349172</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoss AG, Lagomarsino VN, Frank S, Hadzi TC, Myers RH, Latourelle JC (2015) Study of plasma-derived miRNAs mimic differences in Huntington&#x2019;s disease brain. Mov Disord 30(14):1961&#x2013;1964. https://doi.org/10.1002/mds.26457</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.26457</ArticleId><ArticleId IdType="pubmed">26573701</ArticleId><ArticleId IdType="pmc">4715548</ArticleId></ArticleIdList></Reference><Reference><Citation>El Fatimy R, Li S, Chen Z, Mushannen T, Gongala S, Wei Z, Balu DT, Rabinovsky R, Cantlon A, Elkhal A, Selkoe DJ, Sonntag KC, Walsh DM, Krichevsky AM (2018) MicroRNA-132 provides neuroprotection for tauopathies via multiple signaling pathways. Acta Neuropathol 136(4):537&#x2013;555. https://doi.org/10.1007/s00401-018-1880-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1880-5</ArticleId><ArticleId IdType="pubmed">29982852</ArticleId><ArticleId IdType="pmc">6132948</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai MJ, Hsu CY, Sheu CC (2017) Amyotrophic lateral sclerosis. N Engl J Med 377(16):1602. https://doi.org/10.1056/NEJMc1710379</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc1710379</ArticleId><ArticleId IdType="pubmed">29048142</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, van den Berg LH, Kiernan MC (2011) Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat Rev Neurol 7(11):639&#x2013;649. https://doi.org/10.1038/nrneurol.2011.153</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.153</ArticleId><ArticleId IdType="pubmed">21989247</ArticleId></ArticleIdList></Reference><Reference><Citation>Greco V, Longone P, Spalloni A, Pieroni L, Urbani A (2019) Crosstalk between oxidative stress and mitochondrial damage: focus on amyotrophic lateral sclerosis. Adv Exp Med Biol 1158:71&#x2013;82. https://doi.org/10.1007/978-981-13-8367-0_5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-13-8367-0_5</ArticleId><ArticleId IdType="pubmed">31452136</ArticleId></ArticleIdList></Reference><Reference><Citation>Manfredi G, Kawamata H (2016) Mitochondria and endoplasmic reticulum crosstalk in amyotrophic lateral sclerosis. Neurobiol Dis 90:35&#x2013;42. https://doi.org/10.1016/j.nbd.2015.08.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2015.08.004</ArticleId><ArticleId IdType="pubmed">26282323</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, Shaw PJ, Simmons Z, van den Berg LH (2017) Amyotrophic lateral sclerosis. Nat Rev Dis Primers 3:17071. https://doi.org/10.1038/nrdp.2017.71</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Parisi C, Napoli G, Pelegrin P, Volonte C (2016) M1 and M2 functional imprinting of primary microglia: role of P2X7 activation and miR-125b. Mediat Inflamm 2016:2989548&#x2013;2989549. https://doi.org/10.1155/2016/2989548</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/2989548</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Zhang C, Guan Y, Chen Y, Lu Q, Jie L, Gao H, Du H, Zhang H, Liu Y, Wang X (2018) Screening the expression characteristics of several miRNAs in G93A-SOD1 transgenic mouse: altered expression of miRNA-124 is associated with astrocyte differentiation by targeting Sox2 and Sox9. J Neurochem 145(1):51&#x2013;67. https://doi.org/10.1111/jnc.14229</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14229</ArticleId><ArticleId IdType="pubmed">28960306</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohm M, May C, Marcus K, Steinbach S, Theis V, Theiss C, Matschke V (2019) The microRNA miR-375-3p and the tumor suppressor NDRG2 are involved in sporadic amyotrophic lateral sclerosis. Cell Physiol Biochem 52(6):1412&#x2013;1426. https://doi.org/10.33594/000000099</Citation><ArticleIdList><ArticleId IdType="doi">10.33594/000000099</ArticleId><ArticleId IdType="pubmed">31075191</ArticleId></ArticleIdList></Reference><Reference><Citation>Klatt CL, Theis V, Hahn S, Theiss C, Matschke V (2019) Deregulated miR-29b-3p correlates with tissue-specific activation of intrinsic apoptosis in an animal model of amyotrophic lateral sclerosis. Cells 8(9). https://doi.org/10.3390/cells8091077</Citation></Reference><Reference><Citation>Li C, Chen Y, Chen X, Wei Q, Cao B, Shang H (2017) Downregulation of MicroRNA-193b-3p promotes autophagy and cell survival by targeting TSC1/mTOR signaling in NSC-34 cells. Front Mol Neurosci 10:160. https://doi.org/10.3389/fnmol.2017.00160</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00160</ArticleId><ArticleId IdType="pubmed">28611587</ArticleId><ArticleId IdType="pmc">5447700</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos-Melo D, Droppelmann CA, He Z, Volkening K, Strong MJ (2013) Altered microRNA expression profile in amyotrophic lateral sclerosis: a role in the regulation of NFL mRNA levels. Mol Brain 6:26. https://doi.org/10.1186/1756-6606-6-26</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-6606-6-26</ArticleId><ArticleId IdType="pubmed">23705811</ArticleId><ArticleId IdType="pmc">3668997</ArticleId></ArticleIdList></Reference><Reference><Citation>De Santis R, Santini L, Colantoni A, Peruzzi G, de Turris V, Alfano V, Bozzoni I, Rosa A (2017) FUS mutant human motoneurons display altered transcriptome and microRNA pathways with implications for ALS pathogenesis. Stem Cell Reports 9(5):1450&#x2013;1462. https://doi.org/10.1016/j.stemcr.2017.09.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.09.004</ArticleId><ArticleId IdType="pubmed">28988989</ArticleId><ArticleId IdType="pmc">5830977</ArticleId></ArticleIdList></Reference><Reference><Citation>Varcianna A, Myszczynska MA, Castelli LM, O'Neill B, Kim Y, Talbot J, Nyberg S, Nyamali I, Heath PR, Stopford MJ, Hautbergue GM, Ferraiuolo L (2019) Micro-RNAs secreted through astrocyte-derived extracellular vesicles cause neuronal network degeneration in C9orf72 ALS. EBioMedicine 40:626&#x2013;635. https://doi.org/10.1016/j.ebiom.2018.11.067</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2018.11.067</ArticleId><ArticleId IdType="pubmed">30711519</ArticleId><ArticleId IdType="pmc">6413467</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawley ZCE, Campos-Melo D, Strong MJ (2017) Novel miR-b2122 regulates several ALS-related RNA-binding proteins. Molecular brain 10(1):46. https://doi.org/10.1186/s13041-017-0326-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-017-0326-7</ArticleId><ArticleId IdType="pubmed">28969660</ArticleId><ArticleId IdType="pmc">5625648</ArticleId></ArticleIdList></Reference><Reference><Citation>Helferich AM, Brockmann SJ, Reinders J, Deshpande D, Holzmann K, Brenner D, Andersen PM, Petri S, Thal DR, Michaelis J, Otto M, Just S, Ludolph AC, Danzer KM, Freischmidt A, Weishaupt JH (2018) Dysregulation of a novel miR-1825/TBCB/TUBA4A pathway in sporadic and familial ALS. Cell Mol Life Sci 75(23):4301&#x2013;4319. https://doi.org/10.1007/s00018-018-2873-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-018-2873-1</ArticleId><ArticleId IdType="pubmed">30030593</ArticleId></ArticleIdList></Reference><Reference><Citation>Oskarsson B, Gendron TF, Staff NP (2018) Amyotrophic lateral sclerosis: an update for 2018. Mayo Clin Proc 93(11):1617&#x2013;1628. https://doi.org/10.1016/j.mayocp.2018.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2018.04.007</ArticleId><ArticleId IdType="pubmed">30401437</ArticleId></ArticleIdList></Reference><Reference><Citation>Volonte C, Apolloni S, Parisi C (2015) MicroRNAs: newcomers into the ALS picture. CNS Neurol Disord Drug Targets 14(2):194&#x2013;207. https://doi.org/10.2174/1871527314666150116125506</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871527314666150116125506</ArticleId><ArticleId IdType="pubmed">25613506</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chio A, Traynor BJ (2014) State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci 17(1):17&#x2013;23. https://doi.org/10.1038/nn.3584</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Emde A, Eitan C, Liou LL, Libby RT, Rivkin N, Magen I, Reichenstein I, Oppenheim H, Eilam R, Silvestroni A, Alajajian B, Ben-Dov IZ, Aebischer J, Savidor A, Levin Y, Sons R, Hammond SM, Ravits JM, Moller T, Hornstein E (2015) Dysregulated miRNA biogenesis downstream of cellular stress and ALS-causing mutations: a new mechanism for ALS. The EMBO journal 34(21):2633&#x2013;2651. https://doi.org/10.15252/embj.201490493</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201490493</ArticleId><ArticleId IdType="pubmed">26330466</ArticleId><ArticleId IdType="pmc">4641530</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CY, Zhang PH, Chen YJ, Wu CL, Tsai HJ (2019) Conditional overexpression of rtn4al in muscle of adult zebrafish displays defects similar to human amyotrophic lateral sclerosis. Mar Biotechnol (NY) 21(1):52&#x2013;64. https://doi.org/10.1007/s10126-018-9857-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10126-018-9857-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L, Shaw PJ (2018) Lost in translation: microRNAs mediate pathological cross-talk between motor neurons and astrocytes. Brain 141(9):2534&#x2013;2536. https://doi.org/10.1093/brain/awy213</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy213</ArticleId><ArticleId IdType="pubmed">30169589</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Wei Q, Chen X, Li C, Cao B, Ou R, Hadano S, Shang HF (2016) Aberration of miRNAs expression in leukocytes from sporadic amyotrophic lateral sclerosis. Front Mol Neurosci 9:69. https://doi.org/10.3389/fnmol.2016.00069</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2016.00069</ArticleId><ArticleId IdType="pubmed">27582688</ArticleId><ArticleId IdType="pmc">4987348</ArticleId></ArticleIdList></Reference><Reference><Citation>De Felice B, Manfellotto F, Fiorentino G, Annunziata A, Biffali E, Pannone R, Federico A (2018) Wide-ranging analysis of MicroRNA profiles in sporadic amyotrophic lateral sclerosis using next-generation sequencing. Front Genet 9:310. https://doi.org/10.3389/fgene.2018.00310</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2018.00310</ArticleId><ArticleId IdType="pubmed">30154826</ArticleId><ArticleId IdType="pmc">6102490</ArticleId></ArticleIdList></Reference><Reference><Citation>Saucier D, Wajnberg G, Roy J, Beauregard AP, Chacko S, Crapoulet N, Fournier S, Ghosh A, Lewis SM, Marrero A, O'Connell C, Ouellette RJ, Morin PJ (2019) Identification of a circulating miRNA signature in extracellular vesicles collected from amyotrophic lateral sclerosis patients. Brain Res 1708:100&#x2013;108. https://doi.org/10.1016/j.brainres.2018.12.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.12.016</ArticleId><ArticleId IdType="pubmed">30552897</ArticleId></ArticleIdList></Reference><Reference><Citation>Liguori M, Nuzziello N, Introna A, Consiglio A, Licciulli F, D'Errico E, Scarafino A, Distaso E, Simone IL (2018) Dysregulation of MicroRNAs and target genes networks in peripheral blood of patients with sporadic amyotrophic lateral sclerosis. Front Mol Neurosci 11:288. https://doi.org/10.3389/fnmol.2018.00288</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00288</ArticleId><ArticleId IdType="pubmed">30210287</ArticleId><ArticleId IdType="pmc">6121079</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa-Romero C, Hur J, Lunn JS, Paez-Colasante X, Bender DE, Yung R, Sakowski SA, Feldman EL (2016) Expression of microRNAs in human post-mortem amyotrophic lateral sclerosis spinal cords provides insight into disease mechanisms. Mol Cell Neurosci 71:34&#x2013;45. https://doi.org/10.1016/j.mcn.2015.12.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2015.12.008</ArticleId><ArticleId IdType="pubmed">26704906</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawley ZCE, Campos-Melo D, Strong MJ (2019) MiR-105 and miR-9 regulate the mRNA stability of neuronal intermediate filaments. Implications for the pathogenesis of amyotrophic lateral sclerosis (ALS). Brain Res 1706:93&#x2013;100. https://doi.org/10.1016/j.brainres.2018.10.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.10.032</ArticleId><ArticleId IdType="pubmed">30385300</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi D, Volanti P, Brambilla L, Colletti T, Spataro R, La Bella V (2018) CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis. J Neurol 265(3):510&#x2013;521. https://doi.org/10.1007/s00415-017-8730-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-017-8730-6</ArticleId><ArticleId IdType="pubmed">29322259</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad A, Bharathi V, Sivalingam V, Girdhar A, Patel BK (2019) Molecular mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral sclerosis. Front Mol Neurosci 12:25. https://doi.org/10.3389/fnmol.2019.00025</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00025</ArticleId><ArticleId IdType="pubmed">30837838</ArticleId><ArticleId IdType="pmc">6382748</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasai T, Tokuda T, Ishigami N, Sasayama H, Foulds P, Mitchell DJ, Mann DM, Allsop D, Nakagawa M (2009) Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Acta Neuropathol 117(1):55&#x2013;62. https://doi.org/10.1007/s00401-008-0456-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0456-1</ArticleId><ArticleId IdType="pubmed">18989684</ArticleId></ArticleIdList></Reference><Reference><Citation>Raheja R, Regev K, Healy BC, Mazzola MA, Beynon V, Von Glehn F, Paul A, Diaz-Cruz C, Gholipour T, Glanz BI, Kivisakk P, Chitnis T, Weiner HL, Berry JD, Gandhi R (2018) Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosis. Muscle Nerve 58(2):261&#x2013;269. https://doi.org/10.1002/mus.26106</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26106</ArticleId><ArticleId IdType="pubmed">29466830</ArticleId><ArticleId IdType="pmc">6103911</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi I, Hama Y, Matsushima M, Hirotani M, Kano T, Hohzen H, Yabe I, Utsumi J, Sasaki H (2015) Identification of plasma microRNAs as a biomarker of sporadic amyotrophic lateral sclerosis. Molecular brain 8(1):67. https://doi.org/10.1186/s13041-015-0161-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-015-0161-7</ArticleId><ArticleId IdType="pubmed">26497046</ArticleId><ArticleId IdType="pmc">4619470</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A, Muller K, Zondler L, Weydt P, Mayer B, von Arnim CA, Hubers A, Dorst J, Otto M, Holzmann K, Ludolph AC, Danzer KM, Weishaupt JH (2015) Serum microRNAs in sporadic amyotrophic lateral sclerosis. Neurobiol Aging 36(9):2660.e2615&#x2013;2660.e2620. https://doi.org/10.1016/j.neurobiolaging.2015.06.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.06.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Benigni M, Ricci C, Jones AR, Giannini F, Al-Chalabi A, Battistini S (2016) Identification of miRNAs as potential biomarkers in cerebrospinal fluid from amyotrophic lateral sclerosis patients. NeuroMolecular Med 18(4):551&#x2013;560. https://doi.org/10.1007/s12017-016-8396-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12017-016-8396-8</ArticleId><ArticleId IdType="pubmed">27119371</ArticleId></ArticleIdList></Reference><Reference><Citation>De Felice B, Annunziata A, Fiorentino G, Borra M, Biffali E, Coppola C, Cotrufo R, Brettschneider J, Giordana ML, Dalmay T, Wheeler G, D'Alessandro R (2014) miR-338-3p is over-expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients. Neurogenetics 15(4):243&#x2013;253. https://doi.org/10.1007/s10048-014-0420-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-014-0420-2</ArticleId><ArticleId IdType="pubmed">25130371</ArticleId></ArticleIdList></Reference><Reference><Citation>Pegoraro V, Merico A, Angelini C (2017) Micro-RNAs in ALS muscle: differences in gender, age at onset and disease duration. J Neurol Sci 380:58&#x2013;63. https://doi.org/10.1016/j.jns.2017.07.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2017.07.008</ArticleId><ArticleId IdType="pubmed">28870590</ArticleId><ArticleId IdType="pmc">5598142</ArticleId></ArticleIdList></Reference><Reference><Citation>Si Y, Cui X, Crossman DK, Hao J, Kazamel M, Kwon Y, King PH (2018) Muscle microRNA signatures as biomarkers of disease progression in amyotrophic lateral sclerosis. Neurobiol Dis 114:85&#x2013;94. https://doi.org/10.1016/j.nbd.2018.02.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.02.009</ArticleId><ArticleId IdType="pubmed">29486297</ArticleId><ArticleId IdType="pmc">5891369</ArticleId></ArticleIdList></Reference><Reference><Citation>Matamala JM, Arias-Carrasco R, Sanchez C, Uhrig M, Bargsted L, Matus S, Maracaja-Coutinho V, Abarzua S, van Zundert B, Verdugo R, Manque P, Hetz C (2018) Genome-wide circulating microRNA expression profiling reveals potential biomarkers for amyotrophic lateral sclerosis. Neurobiol Aging 64:123&#x2013;138. https://doi.org/10.1016/j.neurobiolaging.2017.12.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.12.020</ArticleId><ArticleId IdType="pubmed">29458840</ArticleId></ArticleIdList></Reference><Reference><Citation>de Andrade HM, de Albuquerque M, Avansini SH, de SRC, Dogini DB, Nucci A, Carvalho B, Lopes-Cendes I, Franca MC, Jr. (2016) MicroRNAs-424 and 206 are potential prognostic markers in spinal onset amyotrophic lateral sclerosis. J Neurol Sci 368:19&#x2013;24. https://doi.org/10.1016/j.jns.2016.06.046</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2016.06.046</ArticleId><ArticleId IdType="pubmed">27538595</ArticleId></ArticleIdList></Reference><Reference><Citation>Pegoraro V, Merico A, Angelini C (2019) MyomiRNAs dysregulation in ALS rehabilitation. Brain Sci 9(1). https://doi.org/10.3390/brainsci9010008</Citation></Reference><Reference><Citation>Brown RH, Al-Chalabi A (2017) Amyotrophic lateral sclerosis. N Engl J Med 377(2):162&#x2013;172. https://doi.org/10.1056/NEJMra1603471</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Glass JD, Hertzberg VS, Boulis NM, Riley J, Federici T, Polak M, Bordeau J, Fournier C, Johe K, Hazel T, Cudkowicz M, Atassi N, Borges LF, Rutkove SB, Duell J, Patil PG, Goutman SA, Feldman EL (2016) Transplantation of spinal cord-derived neural stem cells for ALS: analysis of phase 1 and 2 trials. Neurology 87(4):392&#x2013;400. https://doi.org/10.1212/wnl.0000000000002889</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0000000000002889</ArticleId><ArticleId IdType="pubmed">27358335</ArticleId><ArticleId IdType="pmc">4977116</ArticleId></ArticleIdList></Reference><Reference><Citation>Angelucci F, Cechova K, Valis M, Kuca K, Zhang B, Hort J (2019) MicroRNAs in Alzheimer&#x2019;s disease: diagnostic markers or therapeutic agents? Front Pharmacol 10:665. https://doi.org/10.3389/fphar.2019.00665</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2019.00665</ArticleId><ArticleId IdType="pubmed">31275145</ArticleId><ArticleId IdType="pmc">6591466</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood H (2018) FDA approves patisiran to treat hereditary transthyretin amyloidosis. Nat Rev Neurol 14(10):570. https://doi.org/10.1038/s41582-018-0065-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0065-0</ArticleId><ArticleId IdType="pubmed">30158561</ArticleId></ArticleIdList></Reference><Reference><Citation>Koval ED, Shaner C, Zhang P, du Maine X, Fischer K, Tay J, Chau BN, Wu GF, Miller TM (2013) Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice. Hum Mol Genet 22(20):4127&#x2013;4135. https://doi.org/10.1093/hmg/ddt261</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt261</ArticleId><ArticleId IdType="pubmed">23740943</ArticleId><ArticleId IdType="pmc">3781640</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O, Jedrychowski MP, Cialic R, Krasemann S, Murugaiyan G, Fanek Z, Greco DJ, Wu PM, Doykan CE, Kiner O, Lawson RJ, Frosch MP, Pochet N, Fatimy RE, Krichevsky AM, Gygi SP, Lassmann H, Berry J, Cudkowicz ME, Weiner HL (2015) Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice. Ann Neurol 77(1):75&#x2013;99. https://doi.org/10.1002/ana.24304</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24304</ArticleId><ArticleId IdType="pubmed">25381879</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma G, Wang Y, Li Y, Cui L, Zhao Y, Zhao B, Li K (2015) MiR-206, a key modulator of skeletal muscle development and disease. Int J Biol Sci 11(3):345&#x2013;352. https://doi.org/10.7150/ijbs.10921</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.10921</ArticleId><ArticleId IdType="pubmed">25678853</ArticleId><ArticleId IdType="pmc">4323374</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams AH, Valdez G, Moresi V, Qi X, McAnally J, Elliott JL, Bassel-Duby R, Sanes JR, Olson EN (2009) MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 326(5959):1549&#x2013;1554. https://doi.org/10.1126/science.1181046</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1181046</ArticleId><ArticleId IdType="pubmed">20007902</ArticleId><ArticleId IdType="pmc">2796560</ArticleId></ArticleIdList></Reference><Reference><Citation>Dirren E, Aebischer J, Rochat C, Towne C, Schneider BL, Aebischer P (2015) SOD1 silencing in motoneurons or glia rescues neuromuscular function in ALS mice. Ann Clin Transl Neurol 2(2):167&#x2013;184. https://doi.org/10.1002/acn3.162</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.162</ArticleId><ArticleId IdType="pubmed">25750921</ArticleId><ArticleId IdType="pmc">4338957</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoica L, Todeasa SH, Cabrera GT, Salameh JS, ElMallah MK, Mueller C, Brown RH Jr, Sena-Esteves M (2016) Adeno-associated virus-delivered artificial microRNA extends survival and delays paralysis in an amyotrophic lateral sclerosis mouse model. Ann Neurol 79(4):687&#x2013;700. https://doi.org/10.1002/ana.24618</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24618</ArticleId><ArticleId IdType="pubmed">26891182</ArticleId><ArticleId IdType="pmc">5374859</ArticleId></ArticleIdList></Reference><Reference><Citation>Stepto A, Gallo JM, Shaw CE, Hirth F (2014) Modelling C9ORF72 hexanucleotide repeat expansion in amyotrophic lateral sclerosis and frontotemporal dementia. Acta Neuropathol 127(3):377&#x2013;389. https://doi.org/10.1007/s00401-013-1235-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1235-1</ArticleId><ArticleId IdType="pubmed">24366528</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Z, Zhang Y, Gendron TF, Bauer PO, Chew J, Yang WY, Fostvedt E, Jansen-West K, Belzil VV, Desaro P, Johnston A, Overstreet K, Oh SY, Todd PK, Berry JD, Cudkowicz ME, Boeve BF, Dickson D, Floeter MK, Traynor BJ, Morelli C, Ratti A, Silani V, Rademakers R, Brown RH, Rothstein JD, Boylan KB, Petrucelli L, Disney MD (2014) Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD/ALS. Neuron 83(5):1043&#x2013;1050. https://doi.org/10.1016/j.neuron.2014.07.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.07.041</ArticleId><ArticleId IdType="pubmed">25132468</ArticleId><ArticleId IdType="pmc">4232217</ArticleId></ArticleIdList></Reference><Reference><Citation>Martier R, Liefhebber JM, Miniarikova J, van der Zon T, Snapper J, Kolder I, Petry H, van Deventer SJ, Evers MM, Konstantinova P (2019) Artificial MicroRNAs targeting C9orf72 can reduce accumulation of intra-nuclear transcripts in ALS and FTD patients. Mol Ther Nucleic Acids 14:593&#x2013;608. https://doi.org/10.1016/j.omtn.2019.01.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2019.01.010</ArticleId><ArticleId IdType="pubmed">30776581</ArticleId><ArticleId IdType="pmc">6378669</ArticleId></ArticleIdList></Reference><Reference><Citation>Dini Modigliani S, Morlando M, Errichelli L, Sabatelli M, Bozzoni I (2014) An ALS-associated mutation in the FUS 3'-UTR disrupts a microRNA-FUS regulatory circuitry. Nat Commun 5:4335. https://doi.org/10.1038/ncomms5335</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms5335</ArticleId><ArticleId IdType="pubmed">25004804</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>